BIXT Message Board Post 26388196 | Bioxytran Inc
home / stock / bixt / bixt message board
steffanhen570
()
Posted on: Sep/03/2023 19:33:11
With a market cap that signals promise, $BIXT is charting a course for growth. The company's dedication to innovation and its commitment to addressing unmet medical needs create an attractive investment opportunity. As investors seek opportunities in the OTC market, Bioxytran Inc.'s standout status serves as a reminder that potential gems can be found with a discerning eye and a focus on companies with solid fundamentals.
News, Short Squeeze, Breakout and More Instantly...
-
BXT-25 is expected to oxygenate the brain BOSTON, MASSACHUSETTS, June 27, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke and Alzheimer's disease, announced that Bioxtran’s...
-
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
-
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...